Endoluten®
Distribution of patients by nosological forms, sex and age. Table 1
Diagnosis Age Group Male Female Total
Dyshormonal myocardial dystrophy 40-59 Control - 10 10
Primary - 18 18
Physiogenic asthenia 18-42 Control 9 - 9
Primary 14 - 14
Conditions after radiation and chemotherapy in 48-76 Control 11 18 29
cancer patients
Primary 14 26 40
Severe manifestations of climacteric syndrome 42-63 Control - 16 16
Primary - 27 27
Total: 48 115 163
The patients were randomized into 2 groups for each nosological form: control groups consisted of
64 people who received conventional treatment for their diseases (1, 2). Patients receiving hormone
replacement therapy were not included in the study.
In addition to the conventional treatment, patients of the primary groups were prescribed ENDO-
LUTEN® 1-3 capsules before meals 2-3 times a day for 15-30 days, depending on the severity of the
pathological process.
RESEARCH METHODS
The study of the effectiveness of the use of ENDOLUTEN® was carried out based on generally accept-
ed research methods. Patients’ complaints were assessed in dynamics, general clinical examination of
blood and urine, biochemical blood test, and electrocardiographic study were conducted. Peripheral
blood lymphocytes’ number and functional activity were assessed using immunological methods. The
content of hormones (FSH and LH) in blood serum was determined by radioimmunoassay. A correc-
tion test and Luscher’s test were used to assess psychophysiological parameters.
RESEARCH RESULTS
Negative manifestations of the climacteric period significantly reduce the working capacity of wom-
en of the most working-age. Therefore, the problem of finding new effective means that can reduce
or completely neutralize pathological conditions in women in the postmenopausal period, preserving
their health and high quality of life, is of particular relevance.
Для таблиц, дозировок и примечаний сверяйтесь с оригинальным PDF: при извлечении текста порядок колонок может измениться.
Из библиотеки Peptides. Авторство и содержание оригинала сохранены. Размещено с разрешения поставщика.